Skip to main content

Table 2 The proportions according to the lengths of chemotherapy

From: The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer

Durations of chemotherapy

n (%)

<6 M

147 (34.2 %)

6~12 M

94 (21.9 %)

12~24 M

139 (32.3 %)

>24 M

50 (11.6 %)

  1. n number of patients, M months